Biosafety testing

#Biosafety testing #Drug discovery #Next generation sequencing #Webinar

Watch now: Discover an NGS-based AVA assay with enhanced sensitivity and specificity

Biopharmaceutical manufacturers are under increasing pressure to deliver safe, reliable products at speed – yet adventitious viral agent (AVA) testing remains one of the most significant bottlenecks in the quality control process. In this on-demand webinar, ViruSure, a global leader in pathogen safety testing, shares how it… Read More

Webinar date:
Supported by Oxford Nanopore Technologies and ViruSure
#News

#Biosafety testing #Drug discovery #Next generation sequencing #Webinar

Webinar: Consolidate multiple assays into a single, comprehensive AVA test

Biopharmaceutical manufacturers are under increasing pressure to deliver safe, reliable products at speed – yet adventitious viral agent (AVA) testing remains one of the most significant bottlenecks in the quality control process. In this on-demand webinar, ViruSure, a global leader in pathogen safety testing, shares how it… Read More

Webinar date:
Supported by Oxford Nanopore Technologies and ViruSure
#News

Biosafety testing
#Biosafety testing #Drug discovery #Next generation sequencing #Webinar

Webinar: How can a single, comprehensive test enable broader viral detection?

Biopharmaceutical manufacturers are under increasing pressure to deliver safe, reliable products at speed – yet adventitious viral agent (AVA) testing remains one of the most significant bottlenecks in the quality control process. In this on-demand webinar, ViruSure, a global leader in pathogen safety testing, shares how it… Read More

Webinar date:
Supported by Oxford Nanopore Technologies and ViruSure
#News

Illustration of a virus
#Biosafety testing #Drug discovery #Next generation sequencing #Webinar

Watch now: Overcome the bottlenecks in AVA testing

Biopharmaceutical manufacturers are under increasing pressure to deliver safe, reliable products at speed – yet adventitious viral agent (AVA) testing remains one of the most significant bottlenecks in the quality control process. In this on-demand webinar, ViruSure, a global leader in pathogen safety testing, shares how it… Read More

Webinar date:
Supported by Oxford Nanopore Technologies and ViruSure
#News

#Biosafety testing #Drug discovery #Next generation sequencing #Webinar

Watch now: The first GMP-validated AVA test using Oxford Nanopore sequencing

Biopharmaceutical manufacturers are under increasing pressure to deliver safe, reliable products at speed – yet adventitious viral agent (AVA) testing remains one of the most significant bottlenecks in the quality control process. In this on-demand webinar, ViruSure, a global leader in pathogen safety testing, shares how it… Read More

Webinar date:
Supported by Oxford Nanopore Technologies and ViruSure
#News

#Biosafety testing #Drug discovery #Next generation sequencing #Webinar

How ViruSure implemented an NGS-based AVA assay with enhanced sensitivity and specificity

Biopharmaceutical manufacturers are under increasing pressure to deliver safe, reliable products at speed – yet adventitious viral agent (AVA) testing remains one of the most significant bottlenecks in the quality control process. Traditional AVA workflows require numerous parallel and sequential assays, often taking weeks to complete and contributing… Read More

Webinar date:
Supported by Oxford Nanopore Technologies and ViruSure
#Webinars

Biosafety testing
#Advanced Therapy Medicinal Products (ATMPs) #Bioluminescence #Biosafety testing #Cell and gene therapy #Microbiology #QA/QC

Enhancing rapid microbiology QC in cell & gene therapy

Dr Jeff Domsic, Product Manager Charles River Laboratories, discusses ATP-bioluminescence testing aligned with new regulatory guidelines. Over the past decade, the emergence of advanced therapy medicinal products (ATMPs) has fundamentally changed the approach to developing, manufacturing, administering, and treating diseases. These advanced modalities show significant promise… Read More

#Exclusive Content #Opinion

Heart in a box
#3D cell culture #Advertorial #Biosafety testing #Cell Science #In vitro assays

Ncyte Heart in a Box: Human iPSC-derived 3D cardiac microtissue

This advertorial for Ncardia appeared in DDW Volume 26 – Issue 2, Spring 2025 Read the digital issue When hearts are on the line, accuracy is vital.  Ncyte® Heart in a Box™ is a high-purity, high-functional cell product that mirrors the human heart’s complexity in vitro, giving you… Read More

#Exclusive Content

Antibodies
#Antibody discovery workflow #Biosafety testing #Infographic #Manufacturing #Monoclonal antibodies

Infographic: Discover how to optimise mAb manufacturing

A new Infographic is now available to download from Thermo Fisher Scientific, entitled ‘Optimize Your mAb Manufacturing with Proven Analytical Strategies‘. Key takeaways: Boost Workflow Efficiency: Discover how end-to-end testing can enhance the efficiency of your monoclonal antibody production process. Ensure Compliance: Learn about the importance of accurate and… Read More

#News

#Antibody discovery workflow #Biosafety testing #Manufacturing #Monoclonal antibodies

Optimize Your mAb Manufacturing with Proven Analytical Strategies

Key takeaways: Boost Workflow Efficiency: Discover how end-to-end testing can enhance the efficiency of your monoclonal antibody production process. Ensure Compliance: Learn about the importance of accurate and precise testing at various production stages to meet or exceed regulatory guidelines. Guarantee Quality: Understand how proper testing ensures product safety, quality, and potency throughout… Read More

#Intelligence #Resources

Biosafety cabinet
#Biosafety testing #Lab technology #Laboratory #Nuaire #Webinar

Discover the benefits of a bespoke biosafety cabinet

A new on-demand webinar is now available to watch for free, entitled ‘Customising biosafety cabinets: A holistic approach‘. Watch this on-demand webinar from Nuaire to learn more about: Situations that may require a bespoke biosafety cabinet (BSC) instead of a standard one The process to collaborate with… Read More

Webinar date:
Brought to you by Nuaire
#News

Biosafety cabinet
#Biosafety testing #Lab technology #Laboratory

Customizing Biosafety Cabinets: A Holistic Approach

Watch this on-demand webinar to learn more about: Situations that may require a bespoke biosafety cabinet (BSC) instead of a standard one The process to collaborate with a manufacturer to build a BSC around your needs Planning for the unique certification and service requirements of a bespoke design… Read More

Webinar date:
Brought to you by Nuaire
#Webinars

Biosafety cabinet
#Automation / robotics #Biosafety testing #Drug discovery #Whitepaper

Whitepaper: Ensure your automation equipment is protected

A new whitepaper is now available from NuAire entitled ‘Bespoke Biosafety: Building a Custom Biosafety Cabinet Around your Laboratory Automation Equipment’. Simply having a biosafety cabinet (BSC) with large enough interior dimensions to house automation equipment is not always sufficient for ensuring proper airflow and adequate protection. In many cases,… Read More

#News

#Automation / robotics #Biosafety testing #Drug discovery

Bespoke biosafety: Building a custom biosafety cabinet

Simply having a biosafety cabinet (BSC) with large enough interior dimensions to house automation equipment is not always sufficient for ensuring proper airflow and adequate protection. In many cases, the equipment may actually interfere with the cabinet’s airflow, creating turbulence and rendering the cabinet ineffective. Download this whitepaper about customised… Read More

#Resources

#ApconiX #Biosafety testing #Drug safety #Interview #Podcast #Sitting Down With podcast

What are the benefits of a target safety assessment?

In a DDW Sitting Down With podcast with Lu Rahman, Ruth Roberts and Claire Sadler, ApconiX, discuss the benefits of performing a target safety assessment (TSA) during drug discovery and development when a biological target is going to be acted on by a drug. The… Read More

#Exclusive Content

#Agilent #Biosafety testing #Drug discovery #In vivo #Infographic #Mitochondria

Learn new ways to identify mitochondrial liability

Download this new mitochondrial toxicity infographic by Agilent and discover the benefits of novel in vitro strategies for consumer safety. Drug-induced mitochondrial dysfunction has been linked to compound attrition, organ toxicity, black-box warnings, and market withdrawals. The infographic will help you: Gain an historical perspective on mitochondrial… Read More

#News